Back to the main directory
Press Release
- Flexsteel Industries, Inc. Reports Strong Fiscal Third Quarter 2024 Results: 8% Sales Growth, Improved Operating Margin, Continued Debt Reduction by BusinessWire
- Wabash Recognized with Two Plant Safety Awards at Mexico and Kentucky Operations by GlobeNewsWire
- Lineage Announces Changes to Board of Directors by BusinessWire
- iPower Schedules Fiscal Third Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET by GlobeNewsWire
- Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results by GlobeNewsWire
- VAALCO Energy, Inc. Announces Publication Of 2023 Sustainability Report by GlobeNewsWire
- Cellectis publie ses résultats financiers du quatrième trimestre 2023 et de l’exercice 2023 by GlobeNewsWire
- UTStarcom Files 2023 Form 20-F by GlobeNewsWire
- Hesai Group to Report First Quarter 2024 Financial Results on Monday, May 20, 2024 by GlobeNewsWire
- Martinrea International Inc. Announces TSX Approval of Normal Course Issuer Bid by GlobeNewsWire
- CVR Partners Reports First Quarter 2024 Results and Announces a Cash Distribution of $1.92 by GlobeNewsWire
- Tyrone Michael Jordan Appointed to FuelCell Energy’s Board of Directors by GlobeNewsWire
- Sun Communities, Inc. Reports 2024 First Quarter Results by GlobeNewsWire
- GOGL – 2024 AGM Results Notification by GlobeNewsWire
- Transocean Ltd. Reports First Quarter 2024 Results by GlobeNewsWire
- BeyondSpring Files 2023 Annual Report on Form 20-F by GlobeNewsWire
- Nexus Industrial REIT Announces First Quarter Results Date by GlobeNewsWire
- SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2024; DECLARES QUARTERLY DIVIDEND OF $0.21 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR TUESDAY, APRIL 30, AT 9:30AM CENTRAL TIME by GlobeNewsWire
- Douglas Dynamics Reports First Quarter 2024 Results by GlobeNewsWire
- Grupo Aeroportuario del Pacifico Announces Filing of 2023 Annual Report and Form 20-F by GlobeNewsWire
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology by GlobeNewsWire
- MercadoLibre, Inc. to Report First Quarter 2024 Financial Results by GlobeNewsWire
- TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer by GlobeNewsWire
- SHARC Energy Announces 2023 Year End Financial Results by GlobeNewsWire
- Sound Financial Bancorp, Inc. Q1 2024 Results by GlobeNewsWire